Enveric Biosciences
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
245 1st St Ste 18, Cambridge, Massachuse...Phone Number
(617) 444-8400Website
www.enveric.comRevenue
-Stock Symbol
ENVBIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Enveric Biosciences
Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its unique discovery and development platform, Psybrary, Enveric has created a robust intellectual property portfolio of new chemical entities for specific mental health indications. Enverics lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders. Enveric is headquartered in Naples, FL with offices in Cambridge, MA and Calgary, AB Canada.Explore more
Enveric Biosciences Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enveric Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Enveric Biosciences has recently received funding, and reach out quickly before it becomes old news!
Enveric Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Enveric Biosciences has new funding data
Product Launch: Get notified when Enveric Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Enveric Biosciences is spiking on competitors!
Click to see if Enveric Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Enveric Biosciences
Earning: See what the market has to say on Enveric Biosciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Enveric Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Enveric Biosciences
Compare insights from companies similar to Enveric Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Enveric Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Enveric Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Enveric Biosciences.
Enveric Biosciences financials insights
Gather financial insights about Enveric Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Share Placement
$8M
2025
Stock Offering
$5M
2026
Private Equity
$5M
Enveric Biosciences Tech Stack
A closer look at the technologies used by Enveric Biosciences
Most Recent Scoops
Funding
Funding
Project
Enveric Biosciences announced the appointment of CPAs P C as independent registered public accounting firm for the fiscal year ending December 31, 2025, subject to stockholder ratification. The majority of voting power present at the meeting approved this appointment.
Audit, Finance, Financial Operations
Project
Research & Development, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
Funding
Funding
Project
Product Management, Intellectual Property, Legal Affairs
Enveric Biosciences News & Media
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors
Appointment strengthens Board with seasoned public company biotech executive following recent Nasdaq direct listing SARASOTA, Fla., April 28, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT), a clinical-stage biotechnology company advancing a novel class of...Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds | INN
Enveric Biosciences, Inc. a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 426,390 shares originally issued in February 2025 and September 2025, having exercise prices of $36.00 and $10.98 ...Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results | INN
In Q3, Enveric continued toward clinical readiness for lead candidate EB-003, targeting neuropsychiatric indications, announcing additional positive data in a preclinical model of PTSD, successful completion of dose range finding studies, and receipt of FDA response to pre-IND meeting request. Enveric Biosciences a biotechnology company advancing next-generation neuroplastogenic small molecules to address ...Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds
Business Wire Press Release.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Enveric Biosciences
Sign Up For FreeTo access detailed company insights
Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its unique discovery and development platform, Psybrary, Enveric has created a robust intellectual property portfolio of new chemical entities... Read More
